Tunneled catheters are safer than peripherally inserted catheters (PICCs) for IBD patients receiving home parenteral nutrition.
Guidelines for treating COVID-19 patients with IBD and pancreatic diseases.
Clinicians do not administer reactive TDM or objective disease activity assessments prior to making changes in biologic therapies in almost a third of patients with IBD.
As of March 25, 2020, there were 87 reports of patients with IBD and COVID-19 in the international Surveillance Epidemiology of Coronavirus Under Research Exclusion database (SECURE-IBD).
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic’s enterprise-wide inflammatory bowel disease (IBD) program has entered a new era, combining novel medical and surgical therapies with pioneering research.
A new study confirms that preoperative pelvic radiation, with or without concurrent chemotherapy, is safe and effective in IBD patients with locally advanced rectal cancer.
Learn how Cleveland Clinic is advancing gastrointestinal care: Examining the link between IBD and liver disease, predicting progression in Barrett’s esophagus and investigating stem cell therapy for Crohn’s disease.
Inflammatory bowel disease patients who undergo ileal pouch-anal anastomosis and whose pouch survives several years without complication are likely to have excellent long-term outcomes, a Cleveland Clinic conditional survival study has found.
The presence of inflammatory bowel disease conveys increased risk of comorbid nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and nonalcoholic cirrhosis, two new Cleveland Clinic epidemiological studies show.
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.